NanOlogy starts Phase IIa for NanoPac in prostate cancer

NanOlogy LLC (Fort Worth, Texas) began a Phase IIa trial to test NanoPac in prostate cancer patients scheduled for prostatectomy.

The open-label, dose-escalation study will evaluate safety

Read the full 263 word article

User Sign In